S1PL-IN-31 (compound ) is an oral active sphingosine-1-phosphate (S1P) lyase inhibitor with the IC 50 of 210 nM. S1PL-IN-31 is Smoothened receptor antagonist with the IC 50 of 440 nM. S1PL-IN-31 can be used for study of experimental autoimmune encephalomyelitis.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > LPL Receptor | Products > Signaling Pathways > Smo
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.